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Introduction
The retinoblastoma (Rb) protein plays a critical role at the restric-
tion point of the cell cycle (Weinberg, 1995). In mammalian 
cells, Rb and its family members p107 and p130 are thought 
to normally ensure cell cycle exit and prevent cells from re-
entering the cell cycle mainly by binding to E2F transcription 
factors, inhibiting the expression of E2F target genes, and re-
modeling chromatin into an inactive state (Classon and Harlow, 
2002;  Cobrinik,  2005;  Gonzalo  and  Blasco,  2005).  In  the 
presence of mitogens, cyclin–Cdk complexes phosphorylate Rb 
family members, relieving the inhibition of E2F targets and 
enabling S phase entry. The compromised ability of cells with 
mutations in the Rb pathway to arrest in G1 is thought to be the 
major basis of its tumor suppressor activity (Sherr, 2004). How-
ever, the Rb family participates in multiple cellular processes, 
and their functional inactivation may also contribute to genomic 
instability and altered terminal differentiation; it is also possible 
that alterations in the Rb pathway have different consequences 
in different cell types (Classon and Harlow, 2002; Dannenberg 
and te Riele, 2006; Burkhart and Sage, 2008). A better under-
standing of the consequences of loss of Rb family function 
in mammalian cells may help to identify novel therapeutic 
strategies against many types of human tumors (Knudsen and 
Knudsen, 2008).
Embryogenesis provides a system to investigate the roles 
of Rb family proteins at the interface between proliferation and 
differentiation. Rb
/ embryos die 13.5–15.5 d after fertiliza-
tion (E13.5–E15.5; Clarke et al., 1992; Jacks et al., 1992; Lee 
et al., 1992). This early embryonic lethality of Rb
/ embryos 
was shown to be the consequence of hypoxic stress caused by 
abnormal placental development: in contrast to germline mutant 
embryos, Rb
/ embryos with wild-type (WT) placentas die at 
birth from marked defects in muscle differentiation (de Bruin 
et al., 2003; MacPherson et al., 2003; Wu et al., 2003; Wenzel 
et al., 2007). p130
/ and p107
/ mice do not have any ob-
vious developmental phenotypes in the 129/Sv and C57BL/6 
genetic backgrounds (Cobrinik et al., 1996; Lee et al., 1996). 
In the same genetic background, p130
/;p107
/ mice die im-
mediately after birth, with differentiation defects in their bones 
T
he ability of progenitor cells to exit the cell cycle 
is essential for proper embryonic development and 
homeostasis, but the mechanisms governing cell 
cycle exit are still not fully understood. Here, we tested 
the requirement for the retinoblastoma (Rb) protein and its 
family members p107 and p130 in G0/G1 arrest and dif-
ferentiation in mammalian cells. We found that Rb family 
triple knockout (TKO) mouse embryos survive until days 
9–11 of gestation. Strikingly, some TKO cells, including 
in epithelial and neural lineages, are able to exit the cell 
cycle in G0/G1 and differentiate in teratomas and in 
culture. This ability of TKO cells to arrest in G0/G1 is   
associated with the repression of key E2F target genes. 
Thus, G1 arrest is not always dependent on Rb family 
members, which illustrates the robustness of cell cycle reg-
ulatory networks during differentiation and allows for the 
identification of candidate pathways to inhibit the expan-
sion of cancer cells with mutations in the Rb pathway.
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at least one Rb family gene), focusing on the embryonic central 
nervous system (Fig. 1, D and E). In the spinal cord at E10.5 
(Fig. 1 D) and the developing cortex at E11.5 (Fig. 1 E), we 
found that Mox2
+/Cre TKO embryos had a pattern of expression 
for the postmitotic neuronal marker nestin and for -tubulin 
III (clone Tuj1) and MAP2 (microtubule associated protein 2), 
which was similar to that in control embryos (Fig. 1, D and E). 
p27, a marker of postmitotic neurons, was up-regulated in both 
TKO and control differentiating neuronal cells (Fig. 1 E). This 
analysis confirmed the histopathological observations that loss 
of Rb family genes in Mox2
+/Cre TKO embryos does not prevent 
the first stages of brain development. However, we also found 
that, as expected from the analysis of Rb/p107 double mutant 
embryos (Berman et al., 2009), the brain and other regions of 
Mox2
+/Cre TKO embryos displayed increased proliferation and 
apoptotic cell death at E11.5, as assayed by immunostaining for 
Ki67 (a marker of cells that have entered the cell cycle; Gerdes 
et al., 1984), phospho-histone H3 (PH3; a G2/M marker), and 
cleaved caspase 3 (CC3; a marker of apoptotic cell death; Fig. 1 E 
and not depicted). Ectopic proliferation and cell death in criti-
cal populations may be responsible for the death of Mox2
+/Cre 
TKO embryos.
These data showing Mox2
+/Cre TKO embryos surviving 
until mid-gestation were surprising given the well-known role 
of Rb family members in the control of proliferation and differ-
entiation. However, these experiments did not allow us to assess 
the extent of Rb and p130 deletion in Mox2
+/cre TKO embryos at 
the level of individual cells, and partial or delayed recombina-
tion of the conditional alleles in critical cell populations might 
be the reason why Mox2
+/Cre TKO embryos survived so late into 
gestation and why some TKO cells were able to differentiate.
To address this limitation, we next sought to generate em-
bryos composed entirely of TKO cells. To this end, diploid mouse 
embryonic stem cells (mESCs) with combined mutations in Rb 
family genes (Dannenberg et al., 2000; Sage et al., 2000) were 
injected into WT tetraploid blastocysts before reimplantation 
(Fig. 2 A; Meissner et al., 2007). p107/p130 mutant embryos 
survive until birth (Cobrinik et al., 1996); accordingly, control 
p107/p130 double knockout mESCs produced live embryos at 
10.5 d of development (E10.5; Fig. 2 B). 7 out of 10 TKO embryos 
collected at E10.5 were dead. The size and morphological features 
of these embryos indicated that they were arrested at a develop-
mental stage between embryonic days E8.5 and E9.5 (Table S1). 
The three remaining TKO embryos were alive but resembled 
an earlier stage of development (E9, or Theiler stage 14; 
Fig. 2 B). Serial sectioning and histopathological analysis of 
the three live TKO embryos showed normal development for 
E9 mouse embryos, with the presence of a well-defined neural 
tube, a cardiac chamber, and mesenchymal tissue (Fig. S2 A). 
These data indicated that TKO embryos can develop until E9. 
The difference between chimeric TKO embryos and Mox2
+/Cre 
TKO embryos may be caused by the activation of Cre; Mox2
+/cre 
TKO embryos begin to express Cre 2 d after the blastocyst 
stage, when TKO mESCs were introduced into tetraploid WT 
embryos. It is also possible that the difference between the two 
experiments is caused by the partial recombination of the con-
ditional alleles in Mox2
+/Cre TKO embryos. Nevertheless, these 
and cartilage (Cobrinik et al., 1996). Recently, the analysis of 
Rb
/;p107
/  mutant  embryos  with  WT  placentas  showed 
lethality around E13.5–E14.5, with cardiac differentiation de-
fects and abnormal proliferation of endothelial cells (Berman 
et al., 2009). These data point to a shared role for Rb family 
members in cell cycle exit and differentiation during embry-
onic development.
Although single or double knockout mouse embryonic 
fibroblasts (MEFs) display a compromised G1 arrest, Rb family 
triple knockout (TKO) MEFs are unable to arrest in G1 in re-
sponse to cytostatic signals (Dannenberg et al., 2000; Sage et al., 
2000; Peeper et al., 2001). Thus, the TKO strategy may uncover 
cellular phenotypes that can be masked by the presence of one 
functional Rb family gene compensating for the loss of the two 
others. In particular, we surmised that deleting the entire Rb 
gene family during embryogenesis might reveal the extent to 
which this gene family is critical for controlling cell cycle exit 
and differentiation in multiple lineages. We generated embry-
onic stem cells and mice simultaneously mutated for Rb, p107, 
and p130. We found that the Rb family is essential for proper 
embryonic development, but the phenotypes of TKO embryonic 
cells undergoing differentiation are less severe than expected. 
Strikingly, some TKO cells are able to arrest in G0/G1 and dif-
ferentiate in teratomas and in culture. These findings provide 
evidence for Rb family–independent cellular pathways that can 
participate in the establishment of cell cycle arrest in G0/G1 in 
differentiating embryonic cells.
Results
Rb family mutant embryos die at  
mid-gestation with normal patterning  
and initial differentiation
To investigate the composite role of Rb family proteins during   
embryogenesis, we first sought to generate Rb family TKO 
mouse embryos with WT placentas to prevent placental defects 
associated with loss of Rb (Wu et al., 2003). To this end, we bred 
conditional TKO mice (condTKO, Rb
lox/lox;p130
lox/lox;p107
/;   
Viatour et al., 2008) to Mox2
+/Cre mice in which Cre expression 
begins at E5.5 in the embryo but not in the placenta (Fig. 1 A;   
Tallquist and Soriano, 2000). Survival analysis of embryos col-
lected from condTKO females bred to Mox2
+/cre Rb
/+;p130
/+; 
p107
+/ males (where  is a deleted conditional allele) sup-
ported a model in which TKO embryos die around E11.5   
(Table I). PCR and immunoblot analysis showed that the deletion 
of the Rb and p130 alleles was very efficient although not always 
complete in this Mox2
+/Cre cross (Fig. 1 B and not depicted), 
potentially explaining the age range of live and dead embryos 
obtained  after  E10.5.  Strikingly,  Mox2
+/Cre  TKO  embryos 
showed normal dorso–ventral and anterior–posterior axes and 
development of major organs such as the heart, the spinal cord, 
the liver, and the brain, with the notable exception of the dorsal 
musculature (Fig. 1 C and Fig. S1; de Bruin et al., 2003).
To  investigate  the  consequences  of  deleting  Rb  family 
genes for cell cycle and cell survival in mouse embryos, we per-
formed immunostaining experiments on sections from Mox2
+/Cre   
TKO and control embryos (Mox2
+/+ embryos heterozygote for 811 G1 arrest in the absence of the Rb family • Wirt et al.
Figure 1.  Mox2
+/cre TKO embryos develop normally until mid-gestation. (A) Strategy to delete the three Rb family genes in embryos with a WT placenta 
using Mox2
+/Cre mice. (B) Rb (left) and p130 (right) were immunoprecipitated (IP) from lysates of Mox2
+/+ and Mox2
+/cre E10.5 littermate embryos, and 
immunoblot analysis was performed with Rb and p130 antibodies, respectively. A direct immunoblot analysis for tubulin serves as a loading control. Protein 
molecular weights are indicated. (C) Representative sagittal sections from a control (CTRL) and Rb family TKO embryo at E11.5. Counterstain: hematoxylin 
and eosin (H&E). He, heart; SC, spinal cord; Co, developing cerebral cortex. (D) Immunofluorescence analysis on sagittal sections of the developing spinal 
cord of an E10.5 TKO embryo (TKO) along with a p107
+/ littermate (CTRL) for nestin (red) and MAP2 (green). DAPI stains DNA in blue. (E) Immuno-
staining (brown signal) of the rostral cortex on control and TKO E11.5 embryos for Tuj1, MAP2, p27, Ki67, PH3 (arrows in the TKO embryo mark ectopically 
dividing cells), and CC3 (the arrowhead in the TKO embryo marks dying cells). Bars, 100 µm.JCB • VOLUME 191 • NUMBER 4 • 2010   812
previously (Sage et al., 2000), and one additional clone came from 
a different targeting strategy (Dannenberg et al., 2000). All clones 
produced teratomas that were dissected and analyzed 3 wk after 
injection. Among the 10 TKO teratomas closely examined, two 
remained mostly undifferentiated and contained immature cells 
and cells with a neuroblastic character, as described previously 
(Dannenberg et al., 2000). However, by histopathological analy-
sis, we also clearly identified multiple differentiated cell types in 
sections from TKO teratomas, including cartilage, smooth mus-
cle, osteoid, neuronal tissue, and various types of epithelia (Fig. 3, 
B, D, F, and H; and not depicted). These histological observations 
were confirmed by immunostaining experiments with markers of 
differentiation: cells in WT and TKO teratomas were positive for 
loracrin, smooth muscle actin (SMA), and mucin, confirming the 
presence of differentiated cells in the ectoderm, mesoderm, and 
endoderm lineages, respectively (Fig. 3, I–K; and not depicted). 
Quantification of the expression of these differentiation markers 
in WT and TKO teratomas did not reveal any significant differ-
ence between the two genotypes (Fig. S3, A and B).
Double  immunostaining  for  CC3  and  the  epithelial 
marker cytokeratin 8 (CK8) also showed that several differenti-
ating epithelial cells in control and in TKO teratomas were not 
undergoing apoptosis (Fig. 3 L and not depicted). Moreover, 
immunostaining for the cell cycle marker Ki67 showed that a 
significant number of CK8
+ TKO cells had exited the cell cycle 
in G0/G1, similar to cells in WT teratomas (Fig. 3, M and N). 
We confirmed these results using CK1, a well-characterized 
postmitotic differentiation marker in the skin (Lu et al., 1994): 
CK1
+ Ki67
– cells could be readily observed in both WT and 
TKO teratomas (Fig. 3, O and P). These experiments confirmed 
that absence of the entire Rb family is compatible with cell fate 
determination and further indicated that differentiation associated 
with cell cycle exit is possible in cells with genetic inactivation of 
the entire Rb gene family.
To investigate cell cycle exit and differentiation in TKO 
cells in a different system, we next produced embryoid bodies 
(EBs) from four independent TKO mESC clones as well as from 
control mESCs (Fig. 4 A). In EBs, differentiating mESCs re-
capitulate some aspects of embryonic development, and retinoic 
acid treatment has been shown to promote neuronal differentia-
tion (Bain et al., 1995). The number and the size of EBs in the 
experiments indicate that the Rb gene family is not essential to 
generate embryos up to mid-gestation.
Similar to what we observed in Mox2
+/cre TKO embryos, 
regions of apoptotic cell death could be identified by immuno-
staining against CC3 in TKO chimeric embryos, including in 
the developing neural tube; staining of WT embryos at the same 
stage showed only very few CC3
+ cells (Fig. 2 C). We also found 
that TKO cells were able to develop into specific lineages; in 
the developing neural tube, TKO cells expressed the neural pro-
genitor marker nestin (Fig. 2 C and Fig. S2 B), whereas TKO 
cells lining the cardiac chamber expressed sarcomeric myosin   
(Fig. S2, C and D), similar to WT embryos. Most cells in WT 
and TKO embryos at E9 were positive for Ki67, as expected for 
a developing embryo (Fig. S2 B and not depicted). For exam-
ple, we found that the majority of sarcomeric myosin-positive   
cells were Ki67
+ both in WT and TKO embryos (Fig. S2 D).   
In contrast, nearly all Tuj1
+ neurons were Ki67
– in the developing 
cortex of WT embryos, but most Tuj1
+ neurons in the cortex of 
TKO embryos were Ki67
+, which is indicative of a strong cell 
cycle defect in these embryos (Fig. 2 D).
Rb family mutant mESCs exit the cell cycle 
and differentiate into multiple cell types in 
teratomas and in culture
A very small number of TKO cells in the cardiac chamber and in 
the spinal cord were negative for Ki67 staining but positive for 
the differentiation markers sarcomeric myosin and Tuj1, respec-
tively (Fig. 2 E and Fig. S2 D). These results suggested that 
some TKO cells might be capable of cell cycle exit in vivo; how-
ever, because of the rarity of these Ki67
 TKO cells and the   
impossibility of following the fate of these cells over extended 
periods of time in vivo, it was unclear whether these cells repre-
sented a true cell cycle arrest independent of the Rb family.   
To address this question, we turned to systems more amenable   
to manipulation and quantification.
When injected under the skin of immunocompromised 
mice, WT mESCs formed teratomas comprised of a variety 
of differentiated endodermal, mesodermal, and ectodermal cell 
types, as expected (Fig. 3, A, C, E, and G; and not depicted). 
We used seven independent clones of TKO mESCs: six were 
generated from independent gene-targeting events as described 
Table I.  Generation of Mox2
+/Cre TKO and control embryos
Embryonic stage 5/6 embryos TKO embryos Total number of embryos collected
alive/total alive/total
E10.5 8/8 1/1 44
E11.5 6/7 3/4 44
E12.5 8/9 1/2 32
E13.5 7/8 0/0 40
E14.5 2/5 0/0 13
E15.5 1/1 1/2 24
E16.5 0/4 0/0 20
Experimental numbers 32/42 6/9 281
Expected numbers 3/16 = 40.68 1/16 = 13.56
Alive embryos were scored as alive based on a beating heart and blood flowing through their umbilical cord. 5/6 embryos have five mutant alleles and one WT   
allele among the six alleles for the three Rb family genes. The overall under-representation of TKO embryos after E10.5 is statistically significant in a χ
2 test (P = 0.01).   
All mice analyzed were in a mixed 129Sv/J:C57BL/6 genetic background.813 G1 arrest in the absence of the Rb family • Wirt et al.
Figure 2.  Chimeric embryos composed of TKO cells develop until E9. (A) Tetraploid WT blastocysts were injected with TKO diploid mESCs to generate 
TKO embryos with a WT placenta. (B) Example of a TKO embryo (TKO, right) along with a p107
/;p130
/ control embryo (CTRL, left). A millimetric 
ruler is shown for scale. Both embryos were harvested at E10.5. (C) Representative hematoxylin-counterstained neural tube sections from control and TKO 
embryos at E9 immunostained for CC3 and nestin, as indicated. Bar, 100 µm. (D) Representative sections from control and TKO E9 cortex immunostained 
for Ki67 (red) and Tuj1 (green). (E) Representative sections from control and TKO E9 spinal cord immunostained with Ki67 (red) and Tuj1 (green). Arrows 
indicate nuclei staining negatively for Ki67 and positively for Tuj1, and arrowheads indicate nuclei that stain positively for both Ki67 and Tuj1. DAPI stains 
DNA in blue. Bars: (C) 100 µm; (D and E) 50 µm.JCB • VOLUME 191 • NUMBER 4 • 2010   814
Figure 3.  TKO cells generate differentiated cells in teratomas. (A–K) Histopathological analysis of WT and TKO teratomas in paraffin sections. Teratomas 
formed with WT and TKO mESCs both showed areas of extensive differentiation, including mucin-producing structures (A and B), cartilage (C and D), 
keratinized epithelium (E and F), and osteoid (G and H). TKO mESCs produce cells that participate in the three major lineages: ectoderm (I; cytokeratin 6,   
CK6 staining in brown), endoderm (J; mucin staining in pink), and mesoderm (K; SMA staining in brown) in teratomas. (L and M) Representative immuno-
staining for CK8 and CC3 (L) and for Ki67 and CK8 (M) on sections from a TKO teratoma. (N) Quantification of the proliferative status of CK8
+ cells in WT 
and TKO teratomas. (O and P) Representative immunostaining for Ki67 (red) and CK1 (green) in WT (O) and TKO (P) teratomas. Arrows point to cells that 
stain negatively for Ki67 and positively for CK1. Bars: (A–M) 100 µm; (O and P) 50 µm.815 G1 arrest in the absence of the Rb family • Wirt et al.
heterogeneous than WT: some TKO neurons failed to retain   
BrdU labeling, but we could also readily identify Tuj1
+ BrdU
+ 
TKO neurons, which indicates that some TKO cells are ca-
pable of terminally exiting the cell cycle upon differentiation   
(Fig. 5 A). Additionally, we performed labeling experiments on   
terminally differentiated cultures of WT and TKO neurons by 
adding BrdU for the last 5 d of differentiation, at a time when the 
majority of WT cells have completed the final cell division and are 
terminally differentiated (Fig. 5 B). As expected, WT neurons   
did not incorporate BrdU under these conditions. Remarkably, we 
could also identify a large number of TKO neurons that did not 
incorporate BrdU under the same conditions (Fig. 5 B). Thus, we 
found that Rb family TKO mESCs are able to stably arrest in 
G0/G1 and differentiate in teratomas and in culture.
Multiple changes in critical cell cycle 
regulatory networks may explain cell cycle 
arrest in differentiating TKO mESCs
Several potential models could explain the ability of Rb family 
TKO cells to arrest in G0/G1. For example, although the Rb 
family is thought to be essential for proper control of the G1/S 
transition, some evidence suggests that cyclin E–CDK2 com-
plexes and Myc transcription factors may control this cell cycle 
transition partly independent of Rb family members (Sears and 
Nevins, 2002; Hwang and Clurman, 2005; Meyer and Penn, 
2008). Another possibility was that in the absence of the Rb 
family, alternative transcriptional mechanisms could repress the 
expression of Rb family target genes, including E2F targets.
To begin to identify potential mechanisms allowing TKO 
cells to arrest in G0/G1, we examined the expression of key cell 
cycle regulators in WT and TKO EBs. Despite the cell cycle   
arrest observed in both WT and TKO cells, we found that posi-
tive regulators of cell cycle progression and E2F targets, includ-
ing E2F1, E2F3a, cyclin A, cyclin B, CDK2, and proliferating 
cell nuclear antigen (PCNA), had elevated protein expression 
in TKO EB samples compared with WT samples (Fig. 6 A).   
These observations are consistent with the absence of inhibi-
tion by Rb family members on E2F activity in these cells. In 
contrast, however, the expression of another well-known E2F 
target and critical cell cycle regulator, cyclin E, was signifi-
cantly lower in TKO cells compared with WT cells (Fig. 6,   
A and B). The levels of repressor E2Fs (E2F4 and E2F3b) were 
similar or slightly lower in TKO cells compared with WT cells 
(Fig. 6 A). The mRNA levels for E2F6, E2F7, and E2F8, three 
members of the E2F that can repress gene expression indepen-
dently of Rb family members (Chen et al., 2009; Lammens   
et al., 2009), were not significantly different between TKO and 
WT EBs (Fig. S4 C). Levels of the two cell cycle inhibitors 
p16 and p27 were slightly increased in TKO cells, whereas the 
levels of p21 were similar in cells from both genotypes (Fig. 6, 
A and B). In vitro kinase assays showed a down-regulation of 
CDK2 kinase activity in TKO EBs compared with TKO mESCs 
(Fig. 6 C), which was similar to the decrease observed in WT 
cells. Thus, one mechanism by which TKO cells may achieve 
cell cycle arrest is inhibition of the kinase activity of CDK2 
complexes by decreased levels of cyclin E and increased levels 
of CDK2 inhibitors.
hanging drops were microscopically indistinguishable between 
the WT, Rb
/, p107
/;p130
/, and TKO cells (unpublished 
data). To examine changes in gene expression occurring in con-
trol and TKO cells during in vitro differentiation, we analyzed 
the genome-wide expression profiles of WT and TKO mESCs 
during differentiation. We found that control and TKO undif-
ferentiated mESCs had nearly identical profiles (Fig. S4 A),   
which supports the idea that Rb family proteins are functionally 
inactivated in cycling mESCs due to high cyclin–Cdk kinase ac-
tivities (Ciemerych and Sicinski, 2005; Conklin and Sage, 2009). 
Although the expression profiles between biological replicates 
of TKO EB samples were more variable than those of WT 
EBs (Fig. S4 B), differentiating TKO mESCs clearly showed 
decreased expression of genes that are associated with undiffer-
entiated mESCs, such as Oct4 and Nanog, and increased expres-
sion of genes associated with cellular differentiation, similar to 
WT cells (Fig. S4 A and not depicted). Thus, loss of Rb family 
genes is compatible with the early stages of the differentiation 
process from mESCs in vitro, mimicking the situation observed 
in embryos.
Although cells were continuously grown in medium con-
taining 15% serum, we found that both WT and TKO EB popu-
lations arrested similarly in G0/G1 upon differentiation (Fig. 4, 
B and C). Control and mutant cells also expressed markers of 
the three developmental lineages in culture (Fig. S3 C), as well 
as markers of postmitotic neuronal cells such as MAP2, Tuj1, 
and NF200 (Neurofilament 200 kD; Fig. 4 D). Double-staining 
experiments for MAP2 and BrdU incorporation revealed that 
the vast majority of TKO cells that have differentiated into ma-
ture neurons in culture from EBs did not actively replicate their 
DNA (Fig. 4, E and F). Co-immunostaining for MAP2 and PH3 
confirmed that most TKO differentiated neurons were not going 
through mitosis (Fig. 4 G). Only a very small number of control 
and TKO cells expressing markers of terminal neuronal differ-
entiation also stained positive for CC3, which suggests that 
TKO neurons are largely viable under these differentiation con-
ditions (Fig. 4 H).
To exclude the possibility that the ability of TKO mESCs 
to terminally differentiate into neurons was specific to this dif-
ferentiation protocol, and to study a more homogeneous popu-
lation of TKO neurons in culture, we turned to an additional 
differentiation protocol. By differentiating mESCs on a layer of 
MS5 feeder cells without retinoic acid treatment, mESCs can 
be directed to efficiently differentiate into cultures of pyramidal 
neurons (Fig. 5; Ideguchi et al., 2010). Under these conditions, 
we again found that TKO mESCs efficiently produced neuronal 
cells expressing markers of terminal differentiation such as 
Tuj1, MAP2, and NF200 (Fig. 5 and not depicted). We next 
performed  long-term  BrdU  labeling  experiments  to  investi-
gate whether TKO mESCs were capable of terminally exiting   
the cell cycle while expressing neuronal markers. First, BrdU was   
added to cultures of WT and TKO neuronal precursor cells (NPCs) 
for 3 d, at a time when most WT NPCs exit the cell cycle. 6 d 
after BrdU was removed from the medium, most WT neurons 
had retained the BrdU label, which indicated that these cells do 
not divide after the onset of neuronal differentiation (Fig. 5 A).   
Under the same conditions, cultures of TKO NPCs were more   JCB • VOLUME 191 • NUMBER 4 • 2010   816
Figure 4.  TKO embryonic stem cells generate differentiated cells in culture. (A) Generation of EBs from mESCs in culture. mESCs were cultured without 
LIF in hanging drops for 3 d. Retinoic acid (RA) was added to induce neuronal differentiation. After three additional days of growth in hanging drops, EBs 
were plated and allowed to differentiate for 1 wk. (B) Cell cycle analysis by propidium iodide staining in WT and TKO mESCs (ES) and EBs. (C) Quantifica-
tion of the cell cycle analysis (n ≥ 3 for each genotype). (D) Immunostaining for the neuronal markers Tuj1 (red) and NF200 (green) in WT and TKO EBs. 
Nuclei were visualized with DAPI (blue). Bar, 100 µm. (E) Immunostaining for the neuronal marker MAP2 (green) and BrdU (red) in WT and TKO EBs. Bar, 
100 µm. (F) Quantification of MAP2
+/BrdU
+ cells. A significantly higher number of TKO neurons are BrdU
+ compared with WT neurons (P = 0.0073), but 
the vast majority of TKO neurons are BrdU
–. (G) Numbers of MAP2
+ cells that are in M phase (stained with PH3) in TKO and control cultures 1 wk after 
re-plating of EBs (n ≥ 3 for each genotype; *, P = 0.0248). (H) Numbers of CC3
+ apoptotic MAP2
+ cells in TKO and control EBs 1 wk after re-plating   
(n = 4 for each genotype). Error bars indicate standard deviation.817 G1 arrest in the absence of the Rb family • Wirt et al.
populations (Fig. 6 D). The similarity between the gene ex-
pression profiles for Myc target genes between WT and TKO 
cells suggests that Myc activity was similarly reduced as cells 
from both genotypes differentiate, and provides a second pos-
sible mechanism by which TKO cells may be able to exit the 
cell cycle.
Based on a list of c-Myc target genes identified by whole-
genome chromatin immunoprecipitation (ChIP) in mESCs 
(Kidder et al., 2008), we found that, as expected, the expres-
sion of the majority of Myc targets was down-regulated in   
differentiated WT  EB  populations  compared  with  mESCs 
(Fig. 6 D and not depicted). The same trend was observed in TKO 
Figure 5.  Postmitotic neurons derived from TKO embryonic stem cells stably exit the cell cycle in culture. (A) Protocol to generate cortical neurons from 
mESCs in culture and to examine the capacity of these neurons to retain BrdU over time. BrdU was added to NPC cultures that were undergoing the final 
round of cell division before becoming terminally differentiated. 6 d after the BrdU pulse, WT and TKO cells were immunostained for BrdU incorporation 
(red) and Tuj1 (green). (B) Long-term BrdU labeling of postmitotic WT and TKO neurons in culture. Neuronal cultures were labeled with BrdU for the last 
5 d of culture and then immunostained for BrdU incorporation (red) and Tuj1 (green). White boxes indicate the area magnified in the panels on the right. 
Individual neurons are shown with arrows. Bars, 100 µm.JCB • VOLUME 191 • NUMBER 4 • 2010   818
transcriptional activator AP2 (P = 1.5 × 10
4) and NRF1 (P = 
7.4 × 10
4). Interestingly, NRF1 is a coregulator of a large set 
of cell cycle and cell metabolism genes with E2F transcription 
factors (Cam et al., 2004). Thus, a decrease or a lack of activa-
tion in the metabolism of lipids and macromolecules is associ-
ated with cell cycle arrest in TKO populations. The presence of 
potential E2F binding sites in the promoter of genes similarly 
repressed during differentiation in TKO and WT cells also sug-
gested that a subset of E2F target genes was repressed during 
the differentiation of TKO cells.
These  observations  led  us  to  specifically  evaluate  E2F   
activity in TKO cells undergoing differentiation. To this end, we 
selected a group of E2F target genes based on whole-genome 
ChIP data for E2Fs in human NTera2 embryonal carcinoma 
cells (see Materials and methods; Xu et al., 2007), a cell type 
with similarities to mESCs and EBs. We examined the expres-
sion levels of these E2F target genes in WT and TKO mESCs 
and found that these genes were generally expressed in WT and 
TKO  undifferentiated  cycling  populations.  In  differentiating 
WT mESCs, the expression of most of these E2F target genes 
decreased, as expected. A subset of these genes remained highly 
expressed in TKO EBs, confirming that some E2F activity was 
deregulated in the absence of Rb family genes (Fig. 7 B). Strik-
ingly, however, we found that a significant number of E2F tar-
get genes were repressed during differentiation in TKO cells   
(Fig. 7 B and Table S4), which is indicative of a program in dif-
ferentiating embryonic cells that leads to the repression of E2F 
target genes independently of the Rb family. We confirmed these 
To  specifically  evaluate  the  expression  of  target  genes 
of the Rb family during the differentiation of TKO mESCs in 
culture, we first used a bioinformatics approach to identify a 
list of potential direct transcriptional targets of Rb, p107, and 
p130 based on genome-wide expression profiles and ChIP data 
(see Materials and methods). When we examined the expres-
sion of these 1,095 selected genes during the differentiation of 
WT and TKO mESCs into EBs, we found four groups of genes 
whose expression depended on the absence or the presence of 
Rb family members during differentiation (D1–D4) and two 
groups whose expression profiles were independent of the Rb 
family (I1 and I2; Fig. 7 A and Table S6). A gene ontology (GO) 
term enrichment analysis focusing on the most significant terms   
(Table S2) indicated that cluster D3 was very significantly en-
riched for genes with functions classically associated with those 
of the Rb/E2F axis, such as DNA metabolism (P = 5.7 × 10
14), 
DNA replication (P = 2.4 × 10
12), M phase (P = 4.4 × 10
10), 
and cell cycle (P = 2.0 × 10
7); genes in this cluster included clas-
sical E2F genes such as Mcm10, Dnmt1, and Tk1. Interestingly, 
cluster D1 was enriched for lipid metabolism (P = 1.2 × 10
6)   
and lipid transport (P = 2 × 10
6). I2 genes were associated 
with biopolymer metabolism (P = 7.6 × 10
6) and intracellular 
part (P = 4.2 × 10
6). A search for consensus binding sites 
for transcription factors in the promoters of the genes in these 
clusters identified E2F/DP as  the most  significant in cluster 
D3 (P = 2.4 × 10
5; Table S3). Cluster I2 also showed some   
potential binding activity for E2F (P = 1.9 × 10
3), but the 
most significant potential binding activities were for the general 
Figure 6.  Low CDK2 and Myc activity in differentiating TKO cells. (A) Immunoblot analysis of cell cycle regulators from three representative WT and 
three representative Rb family TKO clones. Tubulin serves as a loading control. Protein molecular weights are indicated. (B) Quantification of cyclin E and 
p21 protein levels in TKO (n = 7) EB extracts relative to the values from WT samples (n = 5) and to tubulin levels. Means ± SEM are shown (error bars).   
(C) In vitro kinase assay on histone H1 for CDK2 in WT and TKO mESC (ES) and EBs (EB) differentiated following the protocol described in Fig. 5. A similar 
reduction of CDK2 kinase activity was observed in TKO EBs differentiated following the protocol shown in Fig. 4 compared with TKO mESCs (not depicted). 
(D) Unsupervised hierarchical clustering of the expression of Myc target genes in WT and TKO mESCs and EBs. Myc target genes were identified from ChIP 
(ChIP-Chip) data (see Materials and methods for details).819 G1 arrest in the absence of the Rb family • Wirt et al.
and MCM3, three essential regulators of cell cycle progression 
at the G1–S transition of the cell cycle (Madine et al., 1995; 
Geng et al., 1996; Le Cam et al., 1999; Hwang and Clurman, 
2005; Tarasov et al., 2008), were among the E2F target genes 
observations by quantitative RT-PCR analysis for the expres-
sion of classical E2F target genes using RNA from independent 
differentiation experiments (Fig. 7 C and Fig. S4, D and E); for 
instance, we found that the genes coding for cyclin E, B-Myb, 
Figure 7.  Repression of Rb family and E2F family transcriptional targets in differentiating TKO cells. (A) Unsupervised hierarchical clustering of the expres-
sion of 1,095 Rb family target genes in WT and TKO mESCs and EBs. Selected results from the search for GO terms and for potential TFs regulating the 
six clusters identified are shown on the right (see Table S6 for the list of genes in each cluster and Tables S2 and S3 for the analyses). (B) Unsupervised 
hierarchical clustering of the expression of E2F target genes in WT and TKO mESCs and EBs. (C) Quantitative RT-PCR analysis of three E2F target genes 
and three critical cell cycle regulators, Cyclin E (Ccne1), B-myb, and Mcm3, whose repression in EBs is independent of the Rb gene family. Means ± SEM 
are shown (error bars). (D) Possible mechanisms of G0/G1 arrest in Rb family TKO cells during embryogenesis. Loss of Rb, p107, and p130 results in the 
activation of activator E2Fs and the loss of repression activity in repressor E2Fs, which is thought to prevent cell cycle exit in G0/G1. Possible mechanisms 
underlying the cell cycle exit observed in some TKO cells during differentiation include a decreased Myc activity, a decreased CDK2 activity, repression of 
several E2F targets (possibly by E2F6-8), and low levels of expression of genes involved in general and lipid metabolism.JCB • VOLUME 191 • NUMBER 4 • 2010   820
of the Rb family (Fig. 7 D). Future experiments will explore 
whether the Rb family–independent cell cycle arrest we observed 
in culture can also occur in vivo by using mice expressing Cre 
in specific, well-defined cell types. We will also pursue ex-
periments to determine whether additional and more subtle 
differentiation phenotypes exist in various TKO cell lineages 
beyond cell death and cell cycle phenotypes (Chen et al., 
2007; McClellan et al., 2007). These experiments will also be 
critical to determine whether the potential mechanisms of G0/G1 
arrest identified in TKO cells in culture are similar or different 
in vivo.
Because no G1 arrest was observed in TKO MEFs grown 
under several cytostatic conditions (Dannenberg et al., 2000; Sage 
et al., 2000), the mechanisms by which TKO embryonic cells   
arrest in G0/G1 are likely to be cell type dependent. However, 
recent observations in flies and mammalian cells suggest several 
models to explain our observations. In Drosophila, feedback 
mechanisms between E2F and cyclin E–CDK2 ensure that cell 
cycle arrest is robust, but these mechanisms vary depending on 
the cell lineage (Buttitta et al., 2007). In mammalian cells, the ki-
nase activity associated with cyclin E–CDK2 is essential for cell 
cycle progression from G0/G1 (van den Heuvel and Harlow, 1993; 
Ohtsubo et al., 1995; Aleem et al., 2005; Ciemerych and Sicinski, 
2005; Hwang and Clurman, 2005; Geng et al., 2007). Expres-
sion of cyclin E is also essential for the enhanced proliferation of 
Rb mutant cells under senescent conditions (Chicas et al., 2010). 
Based on these observations, one possibility to explain the G0/G1 
arrest observed in TKO cells is a concomitant decrease in E2F 
transcriptional activity and in cyclin E–associated kinase activity 
(Fig. 7 D). Indeed, CDK2 activity is decreased in TKO cells, and 
a subset of E2F targets essential for cell cycle progression, includ-
ing the gene coding for cyclin E itself, are similarly repressed in 
WT and TKO differentiating cells. Interestingly, RNA levels for 
cyclin E are similar in WT and TKO cells, whereas the protein 
levels are lower in TKO cells, which suggests that additional post-
transcriptional mechanisms are at play to down-regulate cyclin E 
activity in the mutant cells. Nevertheless, the mechanisms that 
ensure proper cell cycle arrest and prevent cell cycle reentry may 
be conserved between flies and mammals and may involve dual 
inhibition of cyclin E–CDK2 activity and key E2F targets.
The mechanisms leading to repression of a large group of 
E2F target genes in TKO cells undergoing differentiation are 
still unknown. E2F1-3a, the “activating” members of the E2F 
family, are not known to have the ability to repress gene tran-
scription in the absence of Rb family members and are thus un-
likely to play a role in this process (Trimarchi and Lees, 2002; 
Chen et al., 2009; Chong et al., 2009; Lammens et al., 2009). 
Similarly, E2F3b-5 are recruited to the DNA by Rb family pro-
teins to repress their target genes; these “repressor” E2F family 
members would not be expected to repress E2F targets in TKO 
cells. Indeed, we found no significant binding of E2F4 at the 
promoter of E2F target genes in TKO cells (unpublished data). 
Therefore, the best candidates for the repression of key E2F tar-
get genes in TKO cells are “atypical” E2F family members, 
which can bind DNA and repress transcription independently   
of Rb family members (Fig. 7 D; Chen et al., 2009; Lammens   
et al., 2009). Interestingly, E2F6, E2F7, and E2F8 play both cell 
similarly repressed in WT and TKO EB populations (Fig. 7 C  
and Fig. S4 D). Similar observations were made with RNA from 
WT and TKO EBs with enriched populations of cortical neu-
rons (Fig. S4 E). Together, these experiments suggest that cells 
with mutations in Rb family genes are able to arrest in G0/G1 in 
culture by repressing several E2F target genes involved in cell 
cycle progression at the G1/S transition of the cell cycle.
Discussion
Retinoblastoma only affects young children and often develops 
in utero (Lohmann and Gallie, 2004). Loss of Rb function is 
also implicated in the development of osteosarcoma in teen-
agers, a time when bone growth is pronounced (Deshpande and 
Hinds, 2006). These observations raise the possibility that loss 
of Rb in progenitor cells is a key initiating event in these two 
cancer types, and possibly in other adult cancers. Indeed, we 
previously found that loss of Rb family genes in early hemato-
poietic progenitors was sufficient to initiate a preleukemic disorder 
(Viatour et al., 2008), and recent observations have corrobo-
rated this model in breast cancer (Jiang et al., 2010). These ob-
servations led us to investigate the role of Rb family members in 
embryonic development at a time when many stem/progenitor 
cells exit the cell cycle and differentiate.
Experiments with viral oncoproteins known to inactivate 
the function of the three Rb family members have suggested 
that the Rb family was important but not always essential for sev-
eral developmental processes (e.g., Kim et al., 1994; Feddersen 
et al., 1997; Callaghan et al., 1999; McCaffrey et al., 1999; 
McLear et al., 2006). One limitation of experiments with these 
viral oncoproteins is the extent to which they inhibit Rb family 
members (e.g., Casanovas et al., 2005). Data from mice with 
combined mutations in Rb family genes have further supported 
a widespread role for Rb, p107, and p130 in the control of cell 
cycle progression and cellular differentiation in many contexts 
(for reviews see Khidr and Chen, 2006; Wikenheiser-Brokamp, 
2006), including in the formation of skeletal muscle (de Bruin 
et al., 2003). However, thus far, whether the Rb family is abso-
lutely required for cell cycle exit during differentiation had not 
been determined. Our original presumption was that mouse em-
bryos with compound genetic inactivation of Rb, p107, and 
p130 would die from several developmental abnormalities.   
Indeed, we found that loss of the Rb gene family results in em-
bryonic lethality at mid-gestation and is accompanied by an   
increase in proliferation and cell death in multiple lineages. 
This widespread increased apoptosis is probably the cause of 
death of TKO embryos between E9 and E11; it correlates well 
with the expression pattern of Rb family genes at this time of 
development (Jiang et al., 1997; Burkhart et al., 2010). These 
data demonstrate that the Rb gene family is essential for proper 
embryonic development, underscoring the role of the Rb path-
way in cellular and organismal homeostasis. Surprisingly, how-
ever, we did not observe any gross defects in organ size, organ 
shape, or patterning in TKO embryos. Furthermore, when TKO 
mESCs are differentiated in culture, we found that some TKO 
cells can stably arrest in G0/G1 and differentiate, uncovering the 
existence of a mechanism to arrest cells in G0/G1 independently 821 G1 arrest in the absence of the Rb family • Wirt et al.
Materials and methods
Mice and generation of embryos
The Rb and p130 conditional knockout alleles and Mox2
+/Cre mice have 
been described previously (Tallquist and Soriano, 2000; Sage et al., 2003; 
Schaffer et al., 2010). Generation of embryos by tetraploid complementa-
tion was performed as described previously (Meissner et al., 2007). In brief, 
three separate TKO mESC clones and one double knockout control from 
which the TKO clones were generated were injected into tetraploid blasto-
cysts and implanted. One of the three TKO clones was generated from an 
independent targeting strategy and provided by J.-H. Dannenberg and   
H. te Riele (Netherlands Cancer Institute, Amsterdam, Netherlands). Pregnan-
cies were terminated at E10.5–E11.5. All mice were studied in a mixed 
129Sv/J:C57BL/6 genetic background. All of the experiments with mice 
were approved by the Stanford University Institutional Animal Care and 
Use Committee.
Teratoma formation from mESCs
Teratomas were produced from 10
6 WT or TKO mESCs injected under the 
skin of nude mice. Approximately 2–3 wk after the injection, when tumors 
were visible under the skin, teratomas were dissected and fixed in 4% para-
formaldehyde overnight for paraffin embedding and sectioning.
Differentiation of mESCs in culture
mESCs  were  plated  without  leukemia  inhibitory  factor  (LIF)  in  hanging 
drops at a density of 2 × 10
5 cells/ml of media. After 3 d in suspension, 
EBs were fed with 10
7 M retinoic acid in media without LIF. After an   
additional  3  d  of  culture  in  hanging  drops,  EBs  were  then  collected, 
washed briefly in PBS, and plated on gelatinized glass coverslips in media 
without LIF. EBs differentiated for 7 d. A complete protocol for the neuronal 
differentiation of mESCs on MS5 feeder cells was performed as described 
previously (Ideguchi et al., 2010), with some modifications. In brief, mESC 
colonies were grown on a layer of MS5 murine stromal cells (Uzan et al., 
1996) for 5 d, then treated with FGF2 for 2 additional days while on 
feeders. Colonies of NPCs were dissociated into single cells and plated on 
polyornithine/fibronectin-coated glass slides. On the second day after plat-
ing, DAPT was added to the media for 2 d to increase the efficiency of neu-
ronal differentiation. Cells were allowed to differentiate for an additional   
8 d, when they were fixed and prepared for immunostaining (Ideguchi et al., 
2010). 10 µM BrdU was added to cultures to monitor proliferation.
Immunostaining
For immunohistochemistry, mouse embryos and teratomas were fixed in 
4% paraformaldehyde and embedded in paraffin; 5 µm sections were de-
waxed and rehydrated in Trilogy buffer (Cell Marque) in a pressure cooker 
for 15 min. For immunofluorescence to detect YFP, embryos were embed-
ded in OCT media, and 10 µm cryosections were cut. EBs were fixed in 
4% paraformaldehyde on glass coverslips, permeabilized in 0.4% Triton 
X-100, and blocked in 50 mM glycine. All sections were blocked in 5%   
serum and incubated with primary antibody overnight at 4°C.
The following primary antibodies were used for immunostaining: 
SMA (Ab15267; Abcam), loracrin (AF62; Covance), NF200 (Ab4680; 
Abcam), neuronal class III -tubulin (Tuj1; MMS-43SP; Covance), microtubule- 
associated protein 2 (Ab5392; Abcam), nestin (MAB353; Millipore), BrdU 
(347580; BD), PH3 (06-570; Millipore), Ki67 (550609; BD), p27 (610241; 
BD), cytokeratin 8 (MMS1841; Covance), cytokeratin 1 (PRB-165P; Co-
vance), sarcomeric myosin (MF-20; Developmental Studies Hybridoma 
Bank), and CC3 (96645; Cell Signaling). After incubation with primary 
antibody overnight, samples were washed, incubated with secondary anti-
bodies (Alexa Fluor 488 [green] and 594 [red]; Invitrogen), and counter-
stained with DAPI. Tissues known to express the antibody of interest were 
used as positive controls, whereas omission of the primary antibodies in 
identical samples was used as a negative control. BrdU immunostaining was 
performed as described previously (MacPherson et al., 2003). All images 
were acquired with a microscope (Eclipse E8000; Nikon) and a camera 
(Retiga OEM Fast; QImaging) using Osteo II Imagine software (Bioquant). 
The following Pan Fluor objectives (Nikon) were used at 25°C: 10× dif-
ferential interference contrast (DIC) L 16 mm, 20× DIC M 2.1 mm, 40× 
DIC M 0.72 mm, and 100× oil DIC H 0.2 mm. All images within the same 
panel were processed similarly using Photoshop (Adobe).
Immunoprecipitation and immunoblotting
For immunoprecipitation experiments, embryos were harvested from preg-
nant females at E11.5 of gestation and snap-frozen on dry ice. Proteins were 
extracted from the tissues by homogenization in lysis buffer with a pestle.   
cycle and developmental roles (Storre et al., 2002; Courel et al., 
2008; Li et al., 2008). E2F6 in particular may play a role in qui-
escent cells (Ogawa et al., 2002), and its repressor functions 
may  be  dependent  on  its  interactions  with  Polycomb  group 
(PcG) protein complexes, which have been involved in embry-
onic development (Trimarchi et al., 2001; Ogawa et al., 2002; 
Attwooll et al., 2005; Courel et al., 2008). Although we did not 
observe  increased  expression  of  these  atypical  E2F  family 
members in our differentiated TKO cells, these factors may be-
come more active or localize to different promoters in the ab-
sence of the Rb family members. Although these experiments 
may be complicated by overlapping functions and compensatory 
mechanisms between the three atypical E2F family members 
(Li et al., 2008), genetic crosses between Rb family mutant mice 
and mice with mutations in atypical E2f genes will help to de-
termine the functional interactions between Rb family members 
and E2F6-8.
It is also possible that the repression of critical cell cycle 
genes that are normally E2F targets has become independent of 
E2F transcription factors in TKO cells and is caused by tran-
scription factors such as YY1 and NRF1. These factors usually   
partner with E2Fs and may be able to replace their activity 
in certain circumstances (Cam et al., 2004; Giangrande et al., 
2004). Indeed, we see significant enrichment for NRF1 bind-
ing sites in the promoters of the Rb-independent target genes 
in our differentiating TKO cells. We also made the intriguing 
observation that several genes in metabolic pathways, including 
lipid metabolism, may be affected by loss of Rb family genes. 
Interestingly, Rb mutant cells in flies are killed by inactivation 
of TSC2, in part by inhibition of de novo lipid synthesis (Li 
et al., 2010). Future experiments will continue to probe this   
potential link between metabolism and the Rb pathway in   
mammalian cells.
Rb, p107, and p130 normally promote the differentiation 
of multiple lineages by controlling the activity of master tran-
scription factors such as MyoD in muscles (Novitch et al., 1999), 
Runx2 in bones (Thomas et al., 2001), and PGC-1 in adipocytes 
(Scimè et al., 2005). However, our data demonstrate that Rb fam-
ily TKO cells are able to fully differentiate, at least in certain 
lineages in teratomas and in culture. These observations sug-
gest that Rb, p107, and p130 are regulators rather than essential 
components of the differentiation program. Increasing evidence 
indicates that cell cycle exit and differentiation programs are not 
always coupled (Buttitta and Edgar, 2007), and the mechanisms 
allowing TKO cells to differentiate may or may not be different 
than those allowing TKO cells to arrest in G0/G1.
Mice with mutations in gene families that were thought to 
be essential for the G1/S transition of the cell cycle are viable 
surprisingly often, emphasizing the plasticity of embryonic de-
velopment in the mouse (Geng et al., 2003; Parisi et al., 2003; 
Kozar et al., 2004; Malumbres et al., 2004; Aleem and Kaldis, 
2006; Berthet et al., 2006; Lee and Sicinski, 2006; Malumbres, 
2007; Santamaría et al., 2007). Pursuing these studies will pro-
vide novel insights into the mechanisms linking extrinsic sig-
nals occurring during development and the intrinsic machinery 
that governs cell cycle progression and differentiation in normal 
and cancer cells.JCB • VOLUME 191 • NUMBER 4 • 2010   822
To isolate a set of E2F target genes, we used genome-wide ChIP-chip 
data from NTera2 human embryonal carcinoma cells (Xu et al., 2007). We 
isolated the top 200 genes bound by E2F1, E2F4, and E2F6 individually 
and then combined the lists. We mapped these genes to their correspond-
ing mouse homologues using reciprocal best BLAST hits between human 
and mouse, resulting in a list of 272 genes (due to overlapping binding 
of multiple E2Fs to the same genes; Table S4). We then isolated the data 
corresponding to these genes from our microarray dataset and performed 
unsupervised hierarchical clustering.
Similarly, to isolate a set of Myc target genes, we used a predefined 
list of Myc targets identified by genome-wide ChIP in mESCs (Kidder et al., 
2008). Using EntrezGene IDs, we then mapped the mouse Myc ESC target 
genes onto our gene expression data and analyzed it by unsupervised 
hierarchical clustering.
To identify a list of genes that may be direct targets of Rb family 
members, we first grouped genes directly bound by both Rb or p130 
in human fibroblasts during quiescence and senescence (Chicas et al., 
2010), which generated 4,104 potential Rb targets. Separately, we cre-
ated a list of genes whose expression is dependent on Rb. We did this 
by isolating genes whose expression changes in mouse cells with muta-
tions in Rb family members in hematopoietic progenitors (Viatour et al., 
2008), and upon ectopic expression of Rb in human Saos2 cells (Saddic   
et al., 2010). For each dataset, we used Significance Analysis of Micro-
arrays (Tusher et al., 2001) to identify genes that are induced or repressed 
upon mutation of Rb or ectopic expression of Rb as compared with con-
trol cells. After combining the three datasets, we identified 4,309 genes 
whose expression was dependent on Rb. The intersection of these two lists 
produced a group of 1,095 target genes that are likely to be direct tran-
scriptional targets of Rb family members. We mapped these genes onto 
our gene expression data and analyzed it by unsupervised hierarchical 
clustering. We found six clusters of genes whose expression depended on 
the absence or the presence of Rb family members during differentiation 
(see Table S6 for a list of the genes). Each cluster was defined as a group 
of genes that, after unsupervised hierarchical clustering, shared a similar 
expression patterns across all of the microarray samples (these were read-
ily visible using the TreeView software; http://rana.lbl.gov/EisenSoftware 
.htm). We performed gene set analysis of these clusters using the “gene 
module map method” implemented in Genomica (Segal et al., 2004). For 
each cluster, we looked for a significant enrichment of GO gene sets (P < 
0.001; Table S2; Ashburner et al., 2000) and gene sets that share cis- 
regulatory transcription factor motifs in their promoters (P < 0.01; Table S3;   
Adler et al., 2007).
Online supplemental material
Fig.  S1  shows  histopathological  analysis  of  representative  control  and 
Mox2
+/Cre TKO embryos, and is related to Fig. 1. Fig. S2 shows histopath-
ological analysis of E9 TKO tetraploid embryos, and is related to Fig. 2.   
Fig. S3 shows immunostaining for markers of each of the three germ cell 
layers in WT and TKO teratomas, and is related to Figs. 5 and 6. Fig. S4 
shows gene expression analysis of WT and TKO mESCs and EBs, and 
is related to Figs. 6–9. Table S1 shows generation of TKO and control 
embryos using the tetraploid complementation method. Table S2 shows 
GO term enrichment analysis (p.001) on genes identified in the clusters 
shown in Fig. 9 A and Table S6. Table S3 shows a transcription factor (TF) 
motifs search (p.01) on genes identified in the clusters shown in Fig. 9 A  
and Table S6. Table S4 lists genes found in the two clusters identified 
in Fig. 9 B. Table S5 shows primers for quantitative RT-PCR analysis of 
gene expression. Table S6 lists genes found in the six clusters identified 
in Fig. 9 A. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201003048/DC1.
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75 µg of lysate was precleared with protein G beads for 2 h at 4°C 
and then immunoprecipitated overnight with 20 µg of Rb monoclonal 
antibody (Rb4.1; Developmental Studies Hybridoma Bank, University of 
Iowa) or p130 polyclonal antibody (610621; BD). Bound proteins were 
eluted from the beads with Laemmli buffer at 95°C for 5 min before 
immunoblot analysis.
Cell pellets for immunoblotting were lysed in whole cell lysis buffer 
(50 mM Tris, pH 7.6, 1% NP-40, 2 mM EDTA, pH 8, 100 mM NaCl, 
and protease inhibitors) and 50 µg of protein, run on a 10% acrylamide 
gel, and transferred to a PVDF membrane (Hybond). Protein concentra-
tions were determined with a standard Bradford protein assay. Membranes 
were probed with the following antibodies: tubulin (T9026; Sigma-Aldrich), 
CDK2 (sc-163-G; Santa Cruz Biotechnology, Inc.), cyclin B1 (sc-245; Santa 
Cruz Biotechnology, Inc.), E2F3 (sc-878; Santa Cruz Biotechnology, Inc.), 
E2F4 (sc-1082; Santa Cruz Biotechnology, Inc.), p21 (sc-397; Santa Cruz 
Biotechnology, Inc.), p16 (sc-468; Santa Cruz Biotechnology, Inc.), cyclin 
E1 (sc-198; Santa Cruz Biotechnology, Inc.), cyclin A2 (sc-751; Santa Cruz 
Biotechnology, Inc.), E2F1 (sc-193X; Santa Cruz Biotechnology, Inc.), and 
p27 (610241; BD). Secondary antibodies conjugated to HRP (Jackson   
ImmunoResearch Laboratories, Inc.) were used at a concentration of 
1:5,000, and signal was detected by chemiluminescence. Protein bands 
for p21 and cyclin E were quantified using the Odyssey Infrared Imaging 
System (LI-COR Biosciences).
For CDK2 kinase assays, cells were lysed using a whole cell lysis 
buffer (50 mM Tris-HCl, pH 7.5, 250 mM NaCl, 10% glycerol, 0.5% Triton 
X-100, and protease and phosphatase inhibitors). Two experiments were 
performed with EB extracts from the general differentiation protocol, and 
one experiment was performed with the directed neuronal differentiation 
protocol. Immunoblot analysis for tubulin was used to confirm equal protein 
amounts. 100 µg of total protein was incubated with 3 µg of a rabbit poly-
clonal antibody against CDK2 (M2; Santa Cruz Biotechnology, Inc.) over-
night at 4°C. Protein A–agarose beads were washed three times with lysis 
buffer and samples were incubated with 20 µl of beads for 2 h at 4°C. Bead 
pellets were washed four times with lysis buffer then four times with kinase 
buffer (50 mM Tris-HCl, pH 7.4, 10 mM MgCl2, and 1 mM DTT). Bead pel-
lets were then incubated for 30 min at 37°C with 2 µg of histone H1, 50 µM 
ATP, and 5 µCi [
32]ATP in kinase buffer. Samples were then boiled for 5 min 
with 20 µl of 4× Laemmli buffer and loaded onto a 15% polyacrylamide gel 
that was subsequently dried for 3 h at 75°C.
Cell cycle and cell death assays
Cells were prepared for cell cycle analysis by fixation in 70% ethanol at 
20°C overnight. Cells were rehydrated in PBS and stained with 20 µg/ml 
propidium iodide in PBS and 20 µg/ml RNase A for 30 min at 37°C, then 
overnight at 4°C. Cells were filtered with a 100 µm filter to obtain single cell 
suspensions. Quantification of cell death was performed by AnnexinV-FITC 
and propidium iodide staining, as described previously (Sage et al., 2000). 
Samples were analyzed using a FACSCalibur apparatus (BD).
Quantitative RT-PCR
Whole  cell  populations  were  collected  and  mRNA  was  isolated  using 
TRIZOL (Invitrogen) according to the manufacturer’s instructions. cDNA syn-
thesis was performed using the DyNAmo cDNA Synthesis kit (Finnzymes), 
with a total of 1 µg of mRNA per synthesis reaction. Quantitative PCR re-
actions were performed using SYBR GreenER qPCR SuperMix (Invitrogen) 
according to the manufacturer’s instructions. The samples were analyzed 
using a 7900HT Detection System with SDS 2.1 software (Applied Biosystems).   
All samples were normalized to a TATA binding protein (TBP) negative con-
trol RT-PCR and performed a minimum of three times. The primer sequences 
used in these experiments are listed in Table S5.
Microarray analysis
Total RNA was extracted with TRIZOL (Invitrogen) from WT and TKO mESCs 
and EBs (three independent replicates were isolated for WT mESCs, TKO 
mESCs, and WT EBs, whereas five replicates were isolated for TKO EBs). 
The RNA was hybridized to Mouse Genome 430 2.0 arrays (Affymetrix) 
according to the manufacturer’s instructions. The Invariant Set Normaliza-
tion method was used to normalize the arrays using dChip software (Li and 
Hung Wong, 2001). Genes selected for analysis had a raw hybridization 
value >10 in all samples. The data were converted to log2 values and then 
mean centered. Cluster (Eisen et al., 1998) was used to carry out unsuper-
vised hierarchical clustering of the genes that changed more than threefold 
from the mean in four or more samples (out of 14). Primary array data can 
be accessed through the National Center for Biotechnology Information 
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